April 2, 2024 - Inbeeo Strategic Market Access & Pricing

Home
What we do

Get in touch

Realize the true value of your healthcare assets.
Get started with Inbeeo today.

Contact us

What we do

Define your value strategy

We offer best-in-class strategy development tailored to your objectives to help realize the full value of your products and technologies.

Optimize your evidence plan

We can help you collect and understand complex data about your asset, indications, and the pricing and access environment, then turn them into simple overviews and strategic insights with impact.

Price your asset right

Our pricing solutions help you achieve a price for your health technology which reflects its true value to patients, different healthcare systems and society as a whole.

Communicate the value

We work with you to gather the evidence, formulate the insights, and create the arguments you need to explain the value of your technology to payers and other key healthcare stakeholders.

Navigate access policies

We help our customers align their internal priorities with external health policy developments to bolster overall success.
Who we are

Get in touch

Realize the true value of your healthcare assets.
Get started with Inbeeo today.

Contact us

Who we are

Our Team

Our team represents a unique combination of expertise gained at leading pharmaceutical companies, leading consultancies, and leading universities.
Our Products

Get in touch

Realize the true value of your healthcare assets.
Get started with Inbeeo today.

Contact us

Our Products

i•vbp

Cloud-based MCDA application that generates custom value frameworks, co-created with Inbeeo to demonstrate the full value of your assets.

i•pec

Access to 100+ vetted international payers, HTA experts and KOLs for advisory boards, qualitative, and quantitative research, with representation across the US, EU, APAC, LATAM, and MENA.

i•las

Inbeeo’s annual roundtable series for global market access and pricing leaders, discussing the latest, product-agnostic developments shaping our industry.
Our Insights

Latest Article

Biosimilar Pricing and Competition: How Political Visibility Shapes Biologic Pricing after Loss of Exclusivity

Introduction Biologics have reshaped the treatment landscape across a broad

Read More »

Our Insights

Perspectives

A deep dive into the world of Market Access. Discover our perspectives on the latest developments in our field.

Project Cases

Discover how we have helped some of our great clients and how we may be able to help you too.

News

Find out what’s going on with Inbeeo, where we’ve been and who we’ve been talking to.
Join our team

Project Cases

Discover how we have helped some of our great clients and how we may be able to help you too.

EU4 Orphan Drug Pricing: List-to-Net Price Analysis | Inbeeo

Price Your Asset Right

Get in touch

Realize the true value of your healthcare assets.
Get started with Inbeeo today.

What we do

Get in touch

Realize the true value of your healthcare assets.
Get started with Inbeeo today.

Who we are

Get in touch

Realize the true value of your healthcare assets.
Get started with Inbeeo today.

Our Products

Latest Article

Biosimilar Pricing and Competition: How Political Visibility Shapes Biologic Pricing after Loss of Exclusivity

Our Insights

Project Cases

Discover how we have helped some of our great clients and how we may be able to help you too.

Exploring Net Price Dynamics of Orphan Drugs: EU4 and US Market Insights

Follow us

Get in touch

Realize the true value of your healthcare assets. Get started with Inbeeo today.

What we do

Get in touch

Realize the true value of your healthcare assets. Get started with Inbeeo today.

Who we are

Get in touch

Realize the true value of your healthcare assets. Get started with Inbeeo today.

Our Products

Latest Article

Biosimilar Pricing and Competition: How Political Visibility Shapes Biologic Pricing after Loss of Exclusivity

Our Insights

Project Cases

Discover how we have helped some of our great clients and how we may be able to help you too.

Exploring Net Price Dynamics of Orphan Drugs: EU4 and US Market Insights

Realize the true value of your healthcare assets.
Get started with Inbeeo today.

Realize the true value of your healthcare assets.
Get started with Inbeeo today.

Realize the true value of your healthcare assets.
Get started with Inbeeo today.